Advertisement
Dr. Kastrissios' presentation, entitled "Communicating the Value ofPharmacodynamic Modeling in Drug Development," will include several casestudies describing how predictive drug-disease models have been used tosupport dose selection, compare the product profile of a new drug versusmarketed competitors utilizing public-source literature data, and communicatemodel-based results to clinical project teams to support program decision-making. Presentation slides from Dr. Kastrissios' talk will be available athttp://www.pharsight.com following the ARCS Congress.
Advertisement
"Model-based drug development has significant value for optimizing drugtherapy and for improving the confidence of drug development decisions," saidShawn O'Connor, president, CEO, and chairman of Pharsight. "Drug developmentteams can benefit from the quantitative application of drug-disease models tosimulate expected clinical responses of new compounds, to support criticalprogram strategies and enhance study design decisions. Pharsight is pleased toparticipate at the ARCS Congress, where we look forward to sharing ourperspective with industry colleagues on the strategic use of modeling andsimulation to improve drug development knowledge, productivity and decision-making."
Further information on the ARCS Congress can be found athttp://www.arcs.com.au.
About Pharsight Corporation
Pharsight Corporation develops and markets integrated products andservices that enable pharmaceutical and biotechnology companies to achievesignificant and enduring improvements in the development and use oftherapeutic products. Pharsight's goal is to help customers reduce the time,cost and risk of drug development, as well as optimize the post-approvalmarketing and use of pharmaceutical products.
Pharsight's approach enhances the fundamental element of drug developmentsuccess: strong decision-making. By adopting the Pharsight approach, customersacquire a new decision-making process with the potential to systematicallyimprove every level and phase of their business and scientific processes.Pharsight Corporation is headquartered in Mountain View, California.Information about Pharsight is available at http://www.pharsight.com.
Registered Trademarks and Trademarks
Pharsight is a registered trademark of Pharsight Corporation. All otherbrand or product names mentioned in this documentation are trademarks orregistered trademarks of their respective companies or organizations.
SOURCE Pharsight Corporation
